Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy (Q40180989)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 January 2007
edit
Language Label Description Also known as
English
Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy
scientific article published on 22 January 2007

    Statements

    Reg IV is a serum biomarker for gastric cancer patients and predicts response to 5-fluorouracil-based chemotherapy (English)
    22 January 2007
    4383-4393

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit